Public biotech 98: the numbers

被引：0
|
作者：
Riku Lähteenmäki
Adam Michael
Andrew Marshall
机构：
来源：
Nature Biotechnology | 1999年 / 17卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Nature Biotechnology's annual survey of public biotechnology companies reveals a maturing sector, but one that is still a long way from converting revenue and R&D dollars into profits.
引用
收藏
页码：429 / 432
页数：3
相关论文
共 50 条
  • [1] Public biotech 98:: the numbers
    Lähteenmäki, R
    Michael, A
    Marshall, A
    NATURE BIOTECHNOLOGY, 1999, 17 (05) : 429 - 432
  • [2] Public biotech: The numbers
    Riku Lähteenmäki
    Adam Michael
    John Hodgson
    Nature Biotechnology, 1998, 16 : 425 - 427
  • [3] Public biotech:: The numbers
    Lähteenmäki, R
    Michael, A
    Hodgson, J
    NATURE BIOTECHNOLOGY, 1998, 16 (05) : 425 - 427
  • [4] Public biotech in 2016—the numbers
    Chris Morrison
    Riku Lähteenmäki
    Nature Biotechnology, 2017, 35 : 623 - 629
  • [5] Public biotech 2010—the numbers
    Brady Huggett
    John Hodgson
    Riku Lähteenmäki
    Nature Biotechnology, 2011, 29 : 585 - 591
  • [6] Public biotech 2008—the numbers
    Brady Huggett
    John Hodgson
    Riku Lähteenmäki
    Nature Biotechnology, 2009, 27 : 710 - 721
  • [7] Public biotech in 2021 — the numbers
    Laura DeFrancesco
    Riku Lähteenmäki
    Nature Biotechnology, 2022, 40 : 1427 - 1427
  • [8] Public biotech 2006—the numbers
    Riku Lähteenmäki
    Stacy Lawrence
    Nature Biotechnology, 2007, 25 : 729 - 737
  • [9] Public biotech 99:: the numbers
    Lähteenmäki, R
    Hodgson, J
    NATURE BIOTECHNOLOGY, 2000, 18 (05) : 499 - 503
  • [10] Public biotech 2009—the numbers
    Brady Huggett
    John Hodgson
    Riku Lähteenmäki
    Nature Biotechnology, 2010, 28 : 793 - 799
12345